Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hemophilia
Pharma
Pfizer confirms patient death in hemophilia drug trial
A patient in a study of Pfizer’s hemophilia drug Hympavzi has passed away, the company and several hemophilia advocacy groups confirmed this week.
Fraiser Kansteiner
Dec 23, 2025 11:05am
ASH: CSL proves 5-year durability of Hemgenix
Dec 7, 2025 12:00pm
ASH: Pfizer's Hympavzi reduces bleeding in hemophilia patients
Dec 6, 2025 4:00pm
Inside the commercial growing pains of hemophilia gene therapies
Sep 12, 2025 10:00am
Sanofi supports film about women’s experiences with hemophilia
Jul 24, 2025 12:20pm
Pfizer's hemophilia drug hits phase 3 data win
Jun 26, 2025 8:00am
